Recent Updates — LIPO

Lipella Pharmaceuticals Inc. entered into an Asset Purchase Agreement with XRAIY on May 14, 2026, following its voluntary Chapter 11 bankruptcy filing on March 30, 2026. The Bankruptcy Court for the Western District of Pennsylvania approved the sale of substantially all company assets to XRAIY LLC or its designee(s) via a Section 363 sale order dated June 4, 2026. Lipella Pharmaceuticals Inc. is a pharmaceutical company focused on developing medical treatments.